Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (371-380 of 504) with videos related to

Pageof 51
Sort By:
Cancer|April 9, 2024
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemiaElias Jabbour, Fadi G Haddad, Koji Sasaki, et al.
Haematologica|March 17, 2018
Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survivalSteven M Kornblau, Peter P Ruvolo, Rui-Yu Wang, et al.
Leukemia|December 26, 2023
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemiaHiroki Akiyama, Ran Zhao, Lauren B Ostermann, et al.
Cancer|February 28, 2019
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemiaChristopher B Benton, Prajwal C Boddu, Courtney D DiNardo, et al.
Blood Cancer Journal|April 24, 2025
Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemiaHiroki Akiyama, Yuki Nishida, Kyung Hee Chang, et al.
Blood Cancer Journal|January 26, 2022
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapySangeetha Venugopal, Koichi Takahashi, Naval Daver, et al.
Leukemia|June 15, 2021
Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AMLYuki Nishida, Ran Zhao, Lauren E Heese, et al.
Haematologica|July 22, 2017
Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndromeNaval Daver, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Blood|April 25, 2013
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutationFarhad Ravandi, Mona Lisa Alattar, Michael R Grunwald, et al.
Leukemia|May 26, 2019
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemiaTakenobu Nii, Varun V Prabhu, Vivian Ruvolo, et al.
Pageof 51

Showing results (371-380 of 504) with videos related to

Sort By:
Pageof 51
Cancer|April 9, 2024
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemiaElias Jabbour, Fadi G Haddad, Koji Sasaki, et al.
Haematologica|March 17, 2018
Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survivalSteven M Kornblau, Peter P Ruvolo, Rui-Yu Wang, et al.
Leukemia|December 26, 2023
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemiaHiroki Akiyama, Ran Zhao, Lauren B Ostermann, et al.
Cancer|February 28, 2019
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemiaChristopher B Benton, Prajwal C Boddu, Courtney D DiNardo, et al.
Blood Cancer Journal|April 24, 2025
Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemiaHiroki Akiyama, Yuki Nishida, Kyung Hee Chang, et al.
Blood Cancer Journal|January 26, 2022
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapySangeetha Venugopal, Koichi Takahashi, Naval Daver, et al.
Leukemia|June 15, 2021
Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AMLYuki Nishida, Ran Zhao, Lauren E Heese, et al.
Haematologica|July 22, 2017
Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndromeNaval Daver, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Blood|April 25, 2013
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutationFarhad Ravandi, Mona Lisa Alattar, Michael R Grunwald, et al.
Leukemia|May 26, 2019
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemiaTakenobu Nii, Varun V Prabhu, Vivian Ruvolo, et al.
Pageof 51